Promising data from ixabepilone cancer trials

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1598, 2007-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selecting Promising Treatments in Randomized Phase II Cancer Trials with an Active Control

By Cheung Ying Kuen  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 494-508

Taylor & Francis Ltd

Access to resources Recommend Favorite

Ixabepilone for the treatment of solid tumors: a review of clinical data

By Denduluri Neelima   Swain Sandra M  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 423-435

Informa Healthcare

Access to resources Recommend Favorite

Ixabepilone delivers in ER− and HER2+ breast cancer

By  

Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Ixabepilone stacks up in metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Ixabepilone: In Locally Advanced or Metastatic Breast Cancer

By Moen Marit D.  

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1471-1481

Adis International

Access to resources Recommend Favorite